Insperity (NSP) Stock Jumps As Q3 Results Revive Margin Hopes
Insperity came into this Q3 2026 report with a stock that had slipped over the past week, then jumped 5.2% to US$48.68 once investors saw the print. The headline is simple: margin repair finally showed up in the income statement.
Behind that one day pop, gross profit reached US$207m and adjusted earnings per share moved to a US$0.22 profit from an adjusted loss a year ago. The market cheered the turnaround story. The accounts still tell a more fragile tale that hinges on whether this margin recovery can stick.
Love Insperity’s margin rebound but uneasy about how fragile that recovery still looks across a full cycle? Benchmark it against a list of solid balance sheet and fundamentals stocks (25 results) to see peers combining healthier profitability with sturdier finances.
Q3 2026 Earnings Summary
- Revenue (Q3 2026 vs. Q3 2025): US$1,651m vs. US$1,623m (up 1.7%)
- Net Income/Loss (Q3 2026 vs. Q3 2025): loss of US$1m vs. loss of US$20m (loss narrowed 95%)
- Basic EPS (Q3 2026 vs. Q3 2025): loss of US$0.02 per share vs. loss of US$0.53 per share (per share loss reduced 96%)
- Gross Profit (Q3 2026 vs. Q3 2025): US$207m vs. US$195m (up 6%)
Tired of reading through another dense block of earnings tables and footnotes just to figure out what Insperity is really doing under the hood? Get the full visual story of the business with an at a glance view of its profitability trendlines and overall financial picture inside the company report for Insperity.
Insperity Margin Play: Early Proof, Not Yet Scale
For bulls arguing that Insperity can turn product, pricing and healthcare levers into a multi year earnings engine, Q3 finally offers a clear test.
"The main thing that has to go right is sustained margin recovery, with healthcare cost controls, benefit plan changes, client mix decisions, HRScale unit economics and operating expense reductions all holding together while small business hiring remains soft."
Gross profit per worksite employee rising 8% and benefits costs contained at a 3.7% increase show the healthcare and pricing changes working together. A 5% reduction in operating expenses and a move from adjusted loss to adjusted EPS of US$0.22 support the margin rebuild, even as paid worksite employees declined 1.8% and remain guided down for 2026.
One Narrative disagrees with today's price. → See where this Narrative says Insperity should trade.
Insperity Bear Case: Margin Fix Without Growth Proof
Bears argue that Insperity’s cost actions and HRScale push may not rebuild true earnings power if underlying client growth keeps stalling.
"HRScale and the Workday partnership are now seen as potentially offsetting softness in the core PEO base, but with limited net benefit to revenue and profit per worksite employee."
Q3 shows exactly that risk. Paid worksite employees fell 1.8% and full year paid employee guidance still points to a small decline. HRScale remains early at roughly 8,000 worksite employees. Margin metrics improved, yet there is still no clear evidence that new platforms are adding growth on top of a shrinking core pool.
Hunt For Quiet Margin Cousins
Insperity just showed how quickly sentiment can change when a fragile margin story starts to stabilize. The real opportunity is spotting stocks that could be undervalued before that shift gets fully reflected.
- Company 1 - 46% below our estimate - use emerging market payment rails to help large merchants expand volumes with higher margin products and automation.
- Company 2 - 34% below our estimate - convert long term optical and solar supply agreements into higher margin hardware for energy and data infrastructure projects.
- Company 3 - 21% below our estimate - add manufacturing capacity focused on high value AI data center optics and photonics packaging for original equipment makers.
Three companies from the same screener. Open all 29 potentially undervalued companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com